Literature DB >> 837967

Plasma levels and half lives of thioridazine and some of its metabolites. II. Low doses in older psychiatric patients.

R G Muusze, F A Vanderheeren.   

Abstract

Plasma-levels of thioridazine, mesoridazine, sulphoridazine and two other metabolites were determined in ten older chronic psychotic patients on thioridazine therapy. The plasma-level before the morning dose of thioridazine was the most reliable parameter for clinical studies. An intra-individual relationship between lower doses of thioridazine and plasma-levels was found. The percentage contribution of psychoactive compounds to the total sum of "thioridazine plus metabolites" ranged from 43-74%. The mean "early disappearance half-life" of thioridazine was 5 hours, and its mean "late disappearance half-life" was 26 hours.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 837967     DOI: 10.1007/BF00562906

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  8 in total

1.  Plasma levels and clinical effects of thioridazine and thiothixene.

Authors:  R Bergling; T Mjorndal; L Oreland; W Rapp; S Wold
Journal:  J Clin Pharmacol       Date:  1975 Feb-Mar       Impact factor: 3.126

2.  Therapeutic effect and plasma level of thioridazine.

Authors:  F E de Jonghe; H J van der Helm; H F Schalken; J H Thiel
Journal:  Acta Psychiatr Scand       Date:  1973       Impact factor: 6.392

3.  Blood levels of thioridazine and some of its metabolites in psychiatric patients. A preliminary report.

Authors:  G Buyze; P F Egberts; R G Muusze; A Poslavsky
Journal:  Psychiatr Neurol Neurochir       Date:  1973 May-Jun

4.  Serum levels of thioridazine in psychiatric patients and healthy volunteers.

Authors:  E Mårtensson; B E Roos
Journal:  Eur J Clin Pharmacol       Date:  1973-10       Impact factor: 2.953

5.  Multicompartment-kinetics and the accumulation plateau.

Authors:  J M van Rossum; A H Tomey
Journal:  Arch Int Pharmacodyn Ther       Date:  1970-11

6.  Determination of phenothiazines in biological samples.

Authors:  J B Ragland; V J Kinross-Wright; R S Ragland
Journal:  Anal Biochem       Date:  1965-07       Impact factor: 3.365

7.  [Therapeutic effect and plasma level of thioridazine in schizophrenic patients (author's transl)].

Authors:  H E Klein; O Chandra; N Matussek
Journal:  Pharmakopsychiatr Neuropsychopharmakol       Date:  1975-05

8.  A method for the fluorimetric determination of thioridazine (Mellaril) or mesoridazine (Lidanil) in plasma.

Authors:  W L Pacha
Journal:  Experientia       Date:  1969-01-15
  8 in total
  5 in total

Review 1.  Plasma level monitoring of antipsychotic drugs.

Authors:  T B Cooper
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

2.  Red blood cell and plasma levels of thioridazine and mesoridazine in schizophrenic patients.

Authors:  A Shvartsburd; V Nwokeafor; R C Smith
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

3.  Thioridazine pharmacokinetic-pharmacodynamic parameters "Wobble" during treatment of tuberculosis: a theoretical basis for shorter-duration curative monotherapy with congeners.

Authors:  Sandirai Musuka; Shashikant Srivastava; Chandima Wasana Siyambalapitiyage Dona; Claudia Meek; Richard Leff; Jotam Pasipanodya; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

4.  Outcome and risks of ultra-long-term treatment with an oral neuroleptic drug. Relationship between perazine serum levels and clinical variables in schizophrenic outpatients.

Authors:  A Pietzcker; A Poppenberg; J Schley; B Müller-Oerlinghausen
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1981

5.  Thioridazine as Chemotherapy for Mycobacterium avium Complex Diseases.

Authors:  Devyani Deshpande; Shashikant Srivastava; Sandirai Musuka; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.